Scientific research underpins our regulatory work and grounds our efforts to improve public health and reduce disease and death caused by tobacco use. In addition to carrying out our own research, CTP conducts research to support regulatory activities through unique interagency partnerships with the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and other FDA Centers such as the National Center for Toxicological Research and the Center for Devices and Radiological Health.
"I think that the work that's being done here, not only the PATH Study, but across the FDA-funded projects, will be looked upon in the future as a groundbreaking, necessary endeavor in order to save lives."
Andrew Hyland, Ph.D., Roswell Park Cancer Institute
Meet some of the people who lead important tobacco regulatory research. In their own words, they share their work, why it is so important to public health, and also why it is important to them.*
These videos represent a cross section of the past and current work in a variety of topics, including perceptions and misperceptions of tobacco products, use of tobacco products and preferences of tobacco users, and the behavioral and physiological effects of using various tobacco products. The studies featured here provide data that informs regulatory decision making and hold the promise to positively impact public health.
*The opinions in these videos reflect the views of individual researchers, and not necessarily the official position of the FDA's Center for Tobacco Products. These videos represent accurate information about the design of these CTP supported studies at the time the interviews were conducted.
Dr. Krishnan-Sarin and her team of researchers at the Yale University Tobacco Center of Regulatory Science study the impact of flavors on tobacco use.
Dr. Strasser discusses his work as a principal investigator researching the advertising, marketing, and labeling of tobacco products and how that affects risk perceptions.
Dr. Hyland discusses the Population Assessment of Tobacco and Health (PATH) Study, a longitudinal study examining tobacco use, attitudes and beliefs, and health indicators.
Dr. Villanti discusses informing policy through through research on nicotine beliefs in young adults, the effect of low-nicotine cigarettes on behavior in vulnerable populations, and menthol cigarette alternatives.
What tobacco-related research is supported by the FDA?
The videos explore a broad range of tobacco research topics, including:
- Diversity of tobacco products
- Toxicity and carcinogenicity
- Adverse health consequences
- Communications about tobacco products
- Tobacco product marketing
- Effects of economics and policies
These studies will provide important new evidence that informs regulatory decision making to positively impact the health of people.